THE Africa Centres for Disease Control and Prevention (Africa CDC) has dropped plans to buy vaccines from the Serum Institute of India, an official confirmed on Thursday.
Raji Tajudeen, head of Division of Public Health Institutes and Research, told Anadolu Agency that the health agency will get entire vaccines from Johnson & Johnson. “As Africa CDC we will be partnering with J&J,” he said.
But he added that the UN-led COVAX facility, a global initiative aimed at equitable access to COVID-19 vaccines, would be providing vaccines produced by the institute.
The world’s largest vaccine manufacturer in India is producing Oxford-AstraZeneca’s coronavirus vaccine for developing countries. The jab is locally known as Covishield.
On Feb. 15, the WHO listed the vaccine for both emergency use and distribution. The African Regulatory Taskforce subsequently endorsed the WHO listing, and the first shipments to Africa were initiated, with Ghana receiving the first consignment.
The
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insidepolitic.co.za
